KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Teva Pharmaceutical Industries (TEVA) Inventory Average (2016 - 2025)

Teva Pharmaceutical Industries (TEVA) has disclosed Inventory Average for 16 consecutive years, with $3.3 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Inventory Average fell 6.66% year-over-year to $3.3 billion, compared with a TTM value of $3.3 billion through Dec 2025, down 6.66%, and an annual FY2025 reading of $3.1 billion, down 11.98% over the prior year.
  • Inventory Average was $3.3 billion for Q4 2025 at Teva Pharmaceutical Industries, down from $3.4 billion in the prior quarter.
  • Across five years, Inventory Average topped out at $4.4 billion in Q1 2021 and bottomed at $3.1 billion in Q1 2025.
  • Average Inventory Average over 5 years is $3.9 billion, with a median of $4.0 billion recorded in 2022.
  • The sharpest move saw Inventory Average increased 4.94% in 2023, then fell 21.53% in 2025.
  • Year by year, Inventory Average stood at $4.0 billion in 2021, then fell by 3.67% to $3.8 billion in 2022, then increased by 4.94% to $4.0 billion in 2023, then fell by 13.7% to $3.5 billion in 2024, then decreased by 6.66% to $3.3 billion in 2025.
  • Business Quant data shows Inventory Average for TEVA at $3.3 billion in Q4 2025, $3.4 billion in Q3 2025, and $3.4 billion in Q2 2025.